CR20160495A - Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas - Google Patents
Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismasInfo
- Publication number
- CR20160495A CR20160495A CR20160495A CR20160495A CR20160495A CR 20160495 A CR20160495 A CR 20160495A CR 20160495 A CR20160495 A CR 20160495A CR 20160495 A CR20160495 A CR 20160495A CR 20160495 A CR20160495 A CR 20160495A
- Authority
- CR
- Costa Rica
- Prior art keywords
- making
- methods
- same
- cell free
- free compositions
- Prior art date
Links
- 230000001413 cellular effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 3
- 239000003981 vehicle Substances 0.000 abstract 3
- 210000001808 exosome Anatomy 0.000 abstract 2
- 210000000130 stem cell Anatomy 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461969694P | 2014-03-24 | 2014-03-24 | |
| US14/577,978 US20150174166A1 (en) | 2013-12-20 | 2014-12-19 | Compositions for Cellular Restoration and Methods of Making and Using Same |
| PCT/US2015/022285 WO2015148534A1 (en) | 2014-03-24 | 2015-03-24 | Cell free compositions for cellular restoration and methods of making and using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20160495A true CR20160495A (es) | 2017-05-29 |
Family
ID=54196315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20160495A CR20160495A (es) | 2014-03-24 | 2015-03-24 | Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP4445915A3 (enExample) |
| JP (2) | JP6471302B2 (enExample) |
| CR (1) | CR20160495A (enExample) |
| WO (1) | WO2015148534A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11286463B2 (en) | 2012-03-08 | 2022-03-29 | Advanced ReGen Medical Technologies, LLC | Reprogramming of aged adult stem cells |
| CR20160307A (es) | 2013-12-20 | 2016-11-08 | Advanced Regen Medical Tech Llc | Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas |
| US10772911B2 (en) | 2013-12-20 | 2020-09-15 | Advanced ReGen Medical Technologies, LLC | Cell free compositions for cellular restoration and methods of making and using same |
| BR112018072198A2 (pt) | 2016-04-29 | 2019-02-12 | Advanced ReGen Medical Technologies, LLC | composição compreendendo micrornas, método de preparação de uma composição de célula-tronco restaurada, formulação farmacêutica e kit |
| US10717981B2 (en) | 2018-01-18 | 2020-07-21 | Advanced ReGen Medical Technologies, LLC | Therapeutic compositions and methods of making and using the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1766053A4 (en) * | 2004-06-02 | 2007-12-12 | Sourcepharm Inc | MICROVESICLES CONTAINING RNA AND METHODS |
| WO2010150783A1 (ja) * | 2009-06-25 | 2010-12-29 | 株式会社 日立メディコ | 医用画像撮影装置 |
| EP2363136A1 (en) * | 2010-03-02 | 2011-09-07 | Fresenius Medical Care Deutschland GmbH | Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease |
| US20120093885A1 (en) * | 2010-10-18 | 2012-04-19 | Northwestern University | Therapeutic vesicles |
| US8747915B1 (en) | 2011-09-14 | 2014-06-10 | Vincent C. Giampapa | Dietary supplement system for multifunctional anti-aging management and method of use |
| WO2013066368A1 (en) * | 2011-10-03 | 2013-05-10 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Use of mirna 126 to produce hematopoietic stem cells |
| US9427450B2 (en) * | 2012-01-31 | 2016-08-30 | Xon Cells, Inc. | Therapeutic immune modulation by stem cell secreted exosomes |
| US9295696B2 (en) * | 2012-06-08 | 2016-03-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Compositions and methods for restoring or rejuvenating stem/progenitor cell function |
| WO2014028493A2 (en) | 2012-08-13 | 2014-02-20 | Cedars-Sinai Medical Center | Exosomes and micro-ribonucleic acids for tissue regeneration |
-
2015
- 2015-03-24 EP EP24177086.6A patent/EP4445915A3/en active Pending
- 2015-03-24 WO PCT/US2015/022285 patent/WO2015148534A1/en not_active Ceased
- 2015-03-24 EP EP15768892.0A patent/EP3122333A4/en not_active Ceased
- 2015-03-24 JP JP2016558732A patent/JP6471302B2/ja active Active
- 2015-03-24 CR CR20160495A patent/CR20160495A/es unknown
-
2018
- 2018-12-18 JP JP2018236137A patent/JP6900358B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4445915A2 (en) | 2024-10-16 |
| JP6900358B2 (ja) | 2021-07-07 |
| EP4445915A3 (en) | 2025-01-22 |
| JP2019052182A (ja) | 2019-04-04 |
| WO2015148534A1 (en) | 2015-10-01 |
| EP3122333A1 (en) | 2017-02-01 |
| EP3122333A4 (en) | 2017-11-29 |
| JP2017510582A (ja) | 2017-04-13 |
| JP6471302B2 (ja) | 2019-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ728072A (en) | Modulators of toll-like receptors for the treatment of hiv | |
| MX2016013457A (es) | Inhibidores de mdm2 y metodos terapeuticos que utilizan el mismo. | |
| MX390014B (es) | Compuestos de dinucleótidos cíclicos y métodos de uso. | |
| CL2016002269A1 (es) | Moduladores alostéricos del núcleo proteico de la hepatitis b. | |
| MX2023003875A (es) | Formulacion de una vacuna peptidica. | |
| MX2017001512A (es) | Compuestos activos hacia bromodominios. | |
| MX2017007641A (es) | Conjugados de anticuerpo-farmaco con inhibidores de bcl-xl permeables en las celulas. | |
| EA201592103A2 (ru) | Способы и композиции для усиления cd4+ регуляторных t-клеток | |
| BR112015022625A2 (pt) | micromatrizes para entrega de agente terapêutico e métodos de uso | |
| EA202090098A1 (ru) | Фармацевтические композиции терапевтически активных соединений | |
| CL2015002897A1 (es) | Inhibidores de bace1 | |
| EA201790650A1 (ru) | Лекарственная форма и способы применения абиратерона ацетата | |
| IN2013MU03583A (enExample) | ||
| EA030957B1 (ru) | Дипептидные и трипептидные эпоксикетонные ингибиторы протеазы | |
| MX389178B (es) | Formulacion de proporcion fija de insulina glargina/lixisenatida. | |
| CL2017003437A1 (es) | Formulación solida oral que contiene irinotecán y método de preparación de la misma | |
| MX373309B (es) | Composiciones antibióticas de ceftolozano. | |
| EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
| EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
| BR112016014880A2 (pt) | Composição farmacêutica incluindo palonosetron | |
| TR201821116A2 (tr) | POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ | |
| CR20160495A (es) | Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas | |
| MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
| PH12017500602A1 (en) | Methods for treating ocular conditions | |
| CL2017000587A1 (es) | Derivados de tetrahidroquinolina como inhibidores de bromodominio |